CBD Treatment of Anxiety Disorders Clinical Study
The Permanente Journal from NIH published a CBD treatment of Anxiety Disorders Clinical Study in 2019. While premised upon CBD demonstrating preliminary efficacy for a range of physical and mental health care problems. Their summary conclusion: Cannabidiol may hold benefits for anxiety-related disorders. Hence recommending controlled clinical studies.
The study’s objective was to determine whether CBD helps improve sleep and/or anxiety in a clinical population. The design involved the clinical application of CBD for anxiety and sleep complaints as an adjunct to usual treatment. And with measurements consisting of sleep and anxiety scores, using validated instruments.
Context of this Cannabidiol (CBD) Study
The authors recognize that interest in CBD as a treatment of a wide range of disorders has exploded. However, few clinical studies of CBD exist in the psychiatric literature. In addition, a surge in scientific publications continues to find preclinical and clinical evidence documenting value for CBD. Especially in some neuropsychiatric disorders, including epilepsy, anxiety, and schizophrenia.
Buy CatnipBill CBD products here
While asserting that evidence points toward a calming effect for CBD treatment of Anxiety disorders in the central nervous system. Hence, undertaking the study at a psychiatric clinic. The design involving the clinical application of CBD for anxiety and sleep complaints as an adjunct to usual treatment.
Measures and Results
So, measurements incorporated sleep and anxiety scores, using validated instruments. While developing a baseline before and after treatment with CBD. The study consisted of 72 adults, with 47 exhibiting various anxiety disorders. Plus 25 with sleep-related disorders. However, the group was studied as a whole regardless of their source disorder.
https://www.catnipbill.com/2019/09/11/clinical-trials-find-cbd-can-help-alleviate-arthritic-pain/
As a result, Anxiety scores decreased in 79% of the patients and remained improved throughout the duration of the study. However, sleep disorders improved in 67% for the first month but then declined in efficacy over time.
CBD Treatment of Anxiety Disorders Clinical Study Conclusion
Most importantly, the CBD treatment of Anxiety Disorders Clinical Study saw no evidence of a safety issue that would limit future studies. In this evaluation, CBD appears to be better tolerated than routine psychiatric medications. As a result, CBD displays promise as a tool for reducing anxiety in clinical populations.
You can read the full study here
